O'Reilly S - Search Results

1

Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis.

Henderson J, Brown M, Horsburgh S, Duffy L, Wilkinson S, Worrell J, Stratton R, O'Reilly S. Henderson J, et al. Rheumatology (Oxford). 2019 Mar 1;58(3):527-535. doi: 10.1093/rheumatology/key327. Rheumatology (Oxford). 2019. PMID: 30462328

2

T cells in systemic sclerosis: a reappraisal.

O'Reilly S, Hügle T, van Laar JM. O'Reilly S, et al. Rheumatology (Oxford). 2012 Sep;51(9):1540-9. doi: 10.1093/rheumatology/kes090. Epub 2012 May 9. Rheumatology (Oxford). 2012. PMID: 22577083 Review.

3

Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.

Hügle T, O'Reilly S, Simpson R, Kraaij MD, Bigley V, Collin M, Krippner-Heidenreich A, van Laar JM. Hügle T, et al. Arthritis Rheum. 2013 Feb;65(2):481-91. doi: 10.1002/art.37738. Arthritis Rheum. 2013. PMID: 23045159 Free PMC article.

4

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors.

Ciechomska M, Huigens CA, Hügle T, Stanly T, Gessner A, Griffiths B, Radstake TR, Hambleton S, O'Reilly S, van Laar JM. Ciechomska M, et al. Ann Rheum Dis. 2013 Aug;72(8):1382-9. doi: 10.1136/annrheumdis-2012-201958. Epub 2012 Dec 6. Ann Rheum Dis. 2013. PMID: 23223421 Free PMC article.

5

Role of interleukin-13 in fibrosis, particularly systemic sclerosis.

O'Reilly S. O'Reilly S. Biofactors. 2013 Nov-Dec;39(6):593-6. doi: 10.1002/biof.1117. Epub 2013 Jul 25. Biofactors. 2013. PMID: 23893513 Review.

6

Role of toll-like receptors in systemic sclerosis.

Ciechomska M, Cant R, Finnigan J, van Laar JM, O'Reilly S. Ciechomska M, et al. Expert Rev Mol Med. 2013 Aug 28;15:e9. doi: 10.1017/erm.2013.10. Expert Rev Mol Med. 2013. PMID: 23985302 Review.

7

Innate immunity in systemic sclerosis pathogenesis.

O'Reilly S. O'Reilly S. Clin Sci (Lond). 2014 Mar;126(5):329-37. doi: 10.1042/CS20130367. Clin Sci (Lond). 2014. PMID: 24219159 Review.

8

Emerging role of epigenetics in systemic sclerosis pathogenesis.

Ciechomska M, van Laar JM, O'Reilly S. Ciechomska M, et al. Genes Immun. 2014 Oct;15(7):433-9. doi: 10.1038/gene.2014.44. Epub 2014 Jul 17. Genes Immun. 2014. PMID: 25030429 Review.

9

MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.

Ciechomska M, O'Reilly S, Suwara M, Bogunia-Kubik K, van Laar JM. Ciechomska M, et al. PLoS One. 2014 Dec 30;9(12):e115596. doi: 10.1371/journal.pone.0115596. eCollection 2014. PLoS One. 2014. PMID: 25549087 Free PMC article. Clinical Trial.

10

Current frontiers in systemic sclerosis pathogenesis.

Ciechomska M, van Laar J, O'Reilly S. Ciechomska M, et al. Exp Dermatol. 2015 Jun;24(6):401-6. doi: 10.1111/exd.12673. Epub 2015 Mar 27. Exp Dermatol. 2015. PMID: 25712746 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters